April 3, 2017
Hybrid molecule LLP2A-Alendronate could have implications for osteonecrosis, fractures, osteoporosis and inflammatory arthritis.
The University of California, Davis, is pleased to announce a licensing agreement with Regenerative Arthritis and Bone Medicine, Inc. (RABOME) for a class of drugs developed at UC Davis that hold potential for treating diseases associated with bone loss and inflammatory arthritis.
May 31, 2017
UC Davis pulmonary rehabilitation patients performed pieces they learned through singing therapy on May 24 in the lobby of UC Davis Medical Center.
May 19, 2017
A pulmonary health researcher and an orthopaedic surgeon have received two of the UC Davis School of Medicine’s highest faculty honors — the Hibbard Williams Extraordinary Achievement Award and the C. John Tupper Prize for Excellence in Teaching.
May 15, 2017
The Society of General Internal Medicine has honored Richard Kravitz with its 2017 Elnora M. Rhodes SGIM Service Award during their annual meeting in Washington, D.C.
April 25, 2017
Findings may account for relatively poor outcomes
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.
March 21, 2017
UC Davis physician takes on direct-to-consumer "low-T" campaigns in JAMA editorial
Direct-to-consumer advertising for drugs to treat testosterone deficiency — or “low T” — increases prescriptions to men for hormone-replacement therapies but may not improve their health, UC Davis physician Richard Kravitz said in an editorial published in the March 21 issue of the Journal of the American Medical Association.
March 15, 2017
The cardiologists, nurses and technicians of Sacramento’s first transcatheter aortic valve replacement (TAVR) team celebrated a milestone on March 6. For five years, they have provided a minimally invasive treatment option to patients with aortic valve stenosis.
UC Davis joins national consortium to find regenerative treatments for dental and craniofacial tissues
March 7, 2017
UC Davis will join other California research institutions in a three-year, $12 million effort to find regenerative treatments for dental, oral and craniofacial deformities and injuries.
March 6, 2017
UC Davis researchers recommend communications training to help bridge the divide
Disagreements between doctors and patients over the priorities of pain treatment are common during primary care office visits, new research from UC Davis Health shows. Patients hope to reduce pain intensity and identify the cause, while physicians aim to improve physical function and reduce medication side effects, including dependency.
March 3, 2017
Hybrid molecule could have implications for osteonecrosis, fractures, osteoporosis and inflammatory arthritis
The University of California, Davis, has reached a licensing agreement with Regenerative Arthritis and Bone Medicine (RABOME) for a class of drugs developed at the university that hold potential for treating diseases associated with bone loss and inflammatory arthritis.
March 1, 2017
The newest member of the UC Davis cardiothoracic surgery team — Paul Perry — was also the newest presenter at this year’s Women’s Heart Care Forum, an annual event designed to empower women to take charge of their heart health.
February 14, 2017
Amparo Villablanca, a nationally renowned specialist on heart disease in women, will provide a free lunchtime address on “Heart Disease: What Every Woman Should Know.”
February 14, 2017
English language fluency may predict patients' status on the transplant waiting list
Language barriers may hinder U.S. kidney transplant candidates’ access to kidney transplantation, according to a new study in the Clinical Journal of the American Society of Nephrology.
December 13, 2016
UC Davis research published in The Lancet
A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer.
November 29, 2016
Black infants had over twice the deaths of whites attributable to lack of optimal breastfeeding, a new study published in the Journal of Pediatrics shows. Black infants also had over three times the rate of necrotizing enterocolitis, a devastating disease of preterm infants, attributable to suboptimal rates of feeding with their mother’s own milk.
October 13, 2016
UC Davis will be part of California Precision Medicine Consortium
The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.
October 5, 2016
The UC Davis Vascular Center celebrated its 10th anniversary Sept. 29 with an event to recognize the surgeons, physicians, nurses, imaging specialists, vascular technologists and clinic staff who provide comprehensive care for patients with blood vessel disease.
September 29, 2016
New study provides a comprehensive picture of the health and economic benefits of breastfeeding
Breastfeeding as recommended — for a total of one year and exclusively for six months — could protect moms as well as their babies from premature death and serious diseases and save the U.S. more than $4.3 billion in health care and related costs, according to a new study published online in Maternal & Child Nutrition.
September 28, 2016
Internal Medicine's Dr. Michael Schivo is one of four former scholars in the CTSC’s mentored research programs to receive a K award from the National Institutes of Health to direct their own independent research studies.
September 12, 2016
Communications coaching can help, but challenges persist
Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.
September 9, 2016
UC Davis Health System’s Women in Medicine and Health Sciences Program, led by Dr. Amparo Villablanca, has been awarded the Group on Women in Medicine and Science (GWIMS) Leadership Award by the Association of American Medical Colleges (AAMC). The program was honored for its role in demonstrating a significant impact on the advancement of women’s careers in academic medicine and science.
September 8, 2016
The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.
August 26, 2016
Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.
August 22, 2016
Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.”
July 25, 2016
Cardiologists at UC Davis Health System have treated the first patient in Northern California with a new bioresorbable stent.
The Absorb vascular scaffold works like a traditional metal stent in opening vessels clogged by fatty deposits. Instead of remaining in the vessel for a lifetime, however, it is made of material similar to dissolving sutures and disappears within three years.
July 21, 2016
Developing cure for Angelman syndrome brings together talented team
The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome, a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.
July 12, 2016
The UC Davis Clinical and Translational Science Center (CTSC) and the wide array of services that have supported innovative biomedical research and led to the development of new treatments for diseases during the past 10 years will continue, thanks to a $27.8 million grant from the National Center for Accelerating Translational Science and the ongoing support from the School of Medicine.
Congratulations Dr. Stephen Henry!
June 24, 2016
Congratulations to Stephen G. Henry, M.D., M.Sc., Division of General Medicine on his recently awarded NIH R21 grant “Harnessing Patient Narratives to Promote Opioid Tapering in Primary Care.” This study will collect primary care patients' stories about opioid medications and then use them to develop a patient education intervention that encourages responsible opioid tapering.
Funding Agency: National Institute on Drug Abuse (NIDA)
Project Period: 07/01/2016 – 06/30/2018.
Risk of autism with intellectual disability linked with maternal immune dysfunction during pregnancy
June 8, 2016
Pregnant women with higher levels of inflammatory cytokines and chemokines, proteins that control communication between cells of the immune system, may be at significantly greater risk of having a child with autism combined with intellectual disability, researchers with the UC Davis MIND Institute have found.
June 7, 2016
Christopher Bowlus, a nationally recognized expert in liver diseases, is the new chief of the Division of Gastroenterology and Hepatology at UC Davis Health System.
June 6, 2016
Tonya Fancher, an associate professor of internal medicine who has overseen a variety of student training programs that focus on underserved populations, has been named the associate dean for Workforce Innovation and Community Engagement at the School of Medicine.
June 2, 2016
Primo "Lucky" Lara to serve as interim director
Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.
May 31, 2016
UC Davis pulmonary medicine specialist Michael Schivo has received funding from the National Institutes of Health to expand his research on the breath biomarkers of lung disease.
UC Davis approved as a comprehensive care center for pulmonary hypertension
May 25, 2016
UC Davis has been designated as a Center of Comprehensive Care by the Pulmonary Hypertension Association (PHA) in recognition of its essential infrastructure and experience in managing and improving outcomes for patients with pulmonary hypertension.
May 2, 2016
An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results, published online in the journal Cancer Research, point to new therapeutic options for this particularly deadly cancer.
April 20, 2016
Award demonstrates commitment to excellence in cancer care and ongoing quality improvement
The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care. The division is the only Northern California QOPI–certified practice also affiliated with an NCI designated cancer center.
April 13, 2016
Vena cava filters benefit a small portion of patients with leg or lung blood clots, but can also increase blood-clot risks
Devices intended to stop potentially deadly blood clots from reaching the lungs can help a small portion of the patients who receive them but can also increase the risk of additional clots, researchers at UC Davis Health System have found.
March 21, 2016
Pair of research grants target solid tumor cancer stem cells, Tay-Sachs disease.
March 21, 2016
Improving healthy behaviors among patients with chronic disease is a priority for physicians, but how best to do so in a meaningful way during brief doctors’ office visits is unclear.
March 18, 2016
Jack MacMillan, clinical professor of internal medicine and palliative care physician at UC Davis, is featured in the next episode of ViewFinder, a locally produced documentary series that airs on Sacramento’s public television station: KVIE-Channel 6.
March 16, 2016
Once again, U.S. News & World Report has ranked UC Davis School of Medicine among America's best medical schools for the quality of its educational programs in primary care and research. The news magazine's annual listing appeared today on the publication's website and will be published in its guidebook, “America's Best Graduate Schools 2017.”
March 15, 2016
Successful approach by UC Davis team shows diminished neuron loss, reduced symptoms and extended life in animal models of Huntington's disease.
March 2, 2016
The California Health Care Foundation (CHCF) has elected Sergio Aguilar-Gaxiola, professor of internal medicine and founding director of the UC Davis Center for Reducing Health Disparities, to its board of directors.
February 26, 2016
UC Davis cardiologists completed their 100th MitraClip case on Feb. 24, a milestone achieved by just a handful of hospitals nationwide. UC Davis Medical Center is the first to reach this mark in the Sacramento region.
January 26, 2016
Findings may lead to novel treatment approaches for peripheral artery disease
An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells. The findings, posted online today in the journal Stem Cells, will help scientists develop new stem cell-based treatment options for peripheral artery disease, a condition which affects about 12 million people in the United States alone.
January 13, 2016
UC Davis’ leadership in Huntington’s disease research received another boost recently when Kyle Fink, a post-doctoral fellow at the Institute for Regenerative Cures, was recognized by the American Academy of Neurology (AAN) for the cutting-edge research findings in gene editing that he presented at the 2015 Society for Neuroscience Annual Meeting.
January 11, 2016
A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next. The study also found that supplemental diagnostic screenings for women with dense breasts find additional breast cancers but also greatly increase false positive results.
January 7, 2015
UC Davis Medical Center has earned certification from The Joint Commission for its left ventricular assist device (LVAD) program, which offers a technological approach to treating advanced heart failure.
The LVAD is a mechanical pump that takes over some of the work of the heart, restoring blood flow and oxygen levels. The device is surgically implanted below the diaphragm and attached to the left ventricle and aorta, and then powered by two external batteries carried in underarm holsters or waist packs.
January 4, 2015
The program aims to simplify and streamline what should be routine preventive health care, but too often is neglected by providers. It began as a pilot project at UC Davis through a grant from the UC’s Center for Health Quality and Innovation and led by UC Davis internal medicine physician and tobacco control researcher Elisa Tong. The university later expanded the program across the entire system.
December 9, 2015
Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.
Jan Nolta and Paul Knoepfler will be joining more than 1,200 other stem cell experts, including bioethicists, government regulators, patient advocates and investors from 40 countries, as they gather to discuss the discoveries and latest developments in regenerative medicine.
November 18, 2015
The Pulmonary Rehabilitation Program at UC Davis Medical Center has been certified by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) for leadership in improving health and quality of life for people with chronic obstructive pulmonary disease (COPD) and other lung diseases.
November 5, 2015
UC Davis researchers have received a four-year, $1.5 million grant from the National Institutes of Health (NIH) to develop a small, wearable sensor that can measure the relationship between environmental exposures and pediatric asthma.
November 4, 2015
Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.
October 7, 2015
Nicholas Kenyon, a nationally recognized expert in obstructive airway disease, has been appointed chief of the Division of Pulmonary, Critical Care and Sleep Medicine and the Gordon A. Wong Professor in Pulmonary and Critical Care Medicine at UC Davis Health System.
September 29, 2015
In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.
August 20, 2015
New York Blood Center (NYBC) [has] announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.
August 13, 2015
Two UC Davis School of Medicine faculty members and a dean emeritus of the school have been recognized with the 2015 Hibbard Williams Extraordinary Achievement Award and the C. John Tupper Prize for Excellence in Teaching.
August 13, 2015
Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer. In early proof-of-concept research, the team took bladder tumors from individual patients, identified actionable mutations and grafted the tumors into mice. From there, the researchers simultaneously tested multiple therapies in the tumor models. Treatments that were effective in the models could then be given to patients. The research was published today in the journal PLoS One.
May 26, 2015
A drug often prescribed to prevent or stall the progress of heart disease may also relieve symptoms of asthma, according to a new study from pulmonary medicine specialists at UC Davis Health System.
Congratulations Dr. Carroll Cross, recipient of the Internal Medicine Career Achievement Award!
April 20, 2015
Dr. Cross is an outstanding mentor to many faculty in the division of Pulmonary/Critical Care Medicine even after year 40 as faculty. He has been our translational research leader for decades, long before the term was defined. Dr. Cross’ career long expertise has been in the fields of cystic fibrosis (CF), alpha-1 antitrypsin (A1AT) deficiency, and the generation and function of reactive oxygen species in the lung.
Congratulations Dr. Cross!
Congratulations Dr. Valentina Medici, recipient of the 2015 Internal Medicine Faculty Research Award!
April 20, 2015
After her graduation summa cum laude with the MD degree from the prestigious University of Padova in 2000 and subsequent fellowship training in Gastroenterology and Hepatology in Germany, Dr. Medici returned to the University of Padova where she began her research on the pathogenesis and management of Wilson disease (WD). This resulted in 8 publications of which she was first author on 5, that were clinical except for 3 that involved rat models of hepatic copper overload. Subsequently she moved to our institution in 2006 to become a visiting Assistant Professor and K30 scholar in our Mentored Clinical Scientist Development Award. Her subsequent research has focused on two areas of alcoholic liver disease (ALD) and WD.
Congratulations Dr. Medici!
Congratulations Dr. Tonya Fancher
March 6, 2015
Congratulations Dr. Tonya Fancher! Dr. Fancher is the recipient of the 2014-2015 Chancellor's Achievement Award for Diversity and Community.
Congratulations Dr. Sanket Dhruva!
August 6, 2014
Sanket Dhruva, M.D. (PGY-6, cardiology) was recently accepted to become a Robert Wood Johnson Clinical Scholar at Yale University from 2015-2017. During medical school and internal medicine residency training at UCSF, he studied FDA regulation and Medicare coverage of medical devices. His work has been published in the New England Journal of Medicine, JAMA, and the British Medical Journal. During his cardiology fellowship at UC Davis, he has gained a better understanding of how devices are used to better the health of patients with cardiovascular disease and hopes to use the two-year clinical scholars program as a transition to an academic career.
Congratulations to the Division of Cardiovascular Medicine
July 24, 2014
Nipavan Chiamvimonvat, M.D. received a VA Merit Review Award, "Regulation of ion channels in the heart." Project Period: 10/01/2014 - 09/30/2018; Amount: $650,000
Javier Lopez, M.D. received a K12 award, “Predicting cardiac recovery after myocardial infarction: building a new quantitative EMR-based and microRNA expression prediction model” funded through CTSC. Project Period: 07/01/14 - 06/30/16; Amount: $200,000
Ye Chen-Izu, Ph.D. is the recipient of the Grant-in-Aid “Mechano-chemotransduction underlying mechanical stress induced arrhythmias,” from the American Heart Association (AHA) Project Period: 07/01/14 - 06/30/16 $140,000
Xiaodong Zhang, Ph.D. was awarded the Beginning Grant in Aid “Novel mechanisms for the regulation of acid –base balance in cardiac myocytesin" from the American Heart Association (AHA). Project Period: 01/01/14 - 12/31/15; Amount: $140,000
John Rutledge, M.D. received an Opportunity Grant “Assessment of cognitive function in mouse metabolic models” through the NIH-sponsored National Mouse Metabolic Phenotypic Center (MMPC). Project Period: 2014 - 2015; Amount: $162,000
The NIH T32 grant "Training Program in Basic and Translational Cardiovascular Sciences" has been renewed for another five years. Co-Program Directors: Nipavan Chiamvimonvat, M.D. and Ann Knowlton, M.D. Project Period: 07/01/2013 - 06/30/2018; Amount: $2,050,000
Nipavan Chiamvimonvat, M.D. was the recipient of a NIH S10 Shared Equipment Grant "In vivo ultrasound imaging system," (VisualSonics Vevo2100). Amount: $400,000
Nipavan Chiamvimonvat, M.D. published a paper "Functional interaction with filamin A and intracellular Ca2+ enhance the surface membrane expression of a small-conductance Ca2+-activated K+ (SK2) channel" in Proceedings of the National Academy of Sciences (PNAS). Click on the link to view the article http://www.pnas.org/content/111/27/9989.full.pdf+html
Ann Knowlton, M.D. received the 2013 Albrecht Fleckenstein Memorial Award for her distinguished work in the field of basic research from the International Academy of Cardiology. Click on the link to view press release http://www.ucdmc.ucdavis.edu/publish/awards/aboutus/8081/?p=index.html